Insurance Denials, Delays Limit Pediatric Asthma Biologics
Approximately 40% of insurance requests for pediatric asthma biologic therapies are denied, with approvals taking more than a month on average.
Category: Products & Treatment
Products & Treatment
Latest
Products & Treatment
Latest
Merck Ph3 Trial to Evaluate Ensifentrine for AECOPD
Merck has begun patient enrollment in the ENHANCE-3 clinical trial to evaluate ensifentrine (Ohtuvayre) for preventing acute exacerbations of COPD.
Products & Treatment
Latest
Capnography and Pulse Oximetry in the PICU
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
Industry & Regulatory News
Latest
CHEST Developing Pulmonary Certification Program for Advanced Practice Providers
The American College of Chest Physicians announced plans to create the first pulmonary-focused education and certification program for advanced practice providers.
Pharmaceuticals
Latest
Mepolizumab Reduced Corticosteroid Use in COPD Patients
Analysis of Phase 3 clinical trials shows mepolizumab cuts annual steroid exposure and high-dose treatment days for COPD patients.
Diagnostics & Testing
Latest
Researchers Improve RNA Extraction from Human Lung Tissue
New RNA extraction techniques overcome barriers to help scientists better evaluate treatments for diseases such as pulmonary fibrosis.
Monitoring & Treatment
Latest
Resmed Introduces Full Face Fabric CPAP Mask
Resmed announced the US introduction of its AirTouch F40, a fabric, full face CPAP mask option. It will be commercially available starting October 28, 2026.